Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Jardiance (empagliflozin) - LillyMedical - Eli Lilly and Company

    medical.lilly.com/us/products/medical-information/diabetes/jardiance

    Can't find what you're looking for? Contact us for answers to your medical questions. Upon verification, doctors and pharmacists have access to Eli Lilly resources. Get answers to questions your patients are asking and report any adverse events or side effects for Jardiance (empagliflozin).

  3. Savings Card | Jardiance® (empagliflozin) tablets

    patient.boehringer-ingelheim.com/us/products/jardiance/type-2-diabetes/savings

    SAVINGS. With a JARDIANCE Savings Card, patients can pay as little as $10* a month for a 1- to 3-month prescription if eligible. Patients will also automatically be re-enrolled after 12 months, as long as they still qualify (savings subject to monthly limits), so they can keep saving money on JARDIANCE.

  4. Jardiance® | Boehringer Ingelheim

    www.boehringer-ingelheim.com/human-health/products/jardiance

    Treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control and to reduce the risk of cardiovascular death in patients with established cardiovascular disease.

  5. MAKE - Home│JARDIANCE

    pro.boehringer-ingelheim.com/products/jardiance

    JARDIANCE ® is indicated in adults for the treatment of chronic kidney disease. In the EMPA-KIDNEY trial, a randomised, parallel-group, double-blind, placebo-controlled study of 6609 patients with CKD, the efficacy and safety profile of JARDIANCE ® 10 mg (n=3304) was evaluated vs placebo (n=3305).

  6. Jardiance Family of Brands | PI and Med Guides

    pro.boehringer-ingelheim.com/us/products/jardiance/overview

    Access prescribing information, medication guides, and websites for the entire Jardiance brand family.

  7. CKD | T2D & eCVD | HF - JARDIANCE® (empagliflozin) tablets

    pro.boehringer-ingelheim.com/us/products/jardiance

    CKD | T2D & eCVD | HF | Jardiance® (empagliflozin) tablets. JARDIANCE is indicated for: Chronic kidney disease. JARDIANCE reduces the risk of sustained eGFR decline, ESKD, CV death, and hospitalization in adults with CKD at risk of progression. Heart failure.

  8. US FDA approves Jardiance® (empagliflozin) for ... - Eli Lilly...

    investor.lilly.com/news-releases/news-release-details/us-fda-approves...

    US FDA approves Jardiance® (empagliflozin) for the treatment of type 2 diabetes in children 10 years and older. - Empagliflozin is the first and only SGLT2 inhibitor approved for this patient population - More than 5,700 young people are diagnosed with type 2 diabetes annually in the U.S.

  9. JARDIANCE® (empagliflozin) for patients | Boehringer Ingelheim

    public.boehringer-ingelheim.com/uk/products/jardiance

    Adult patients can access an overview and additional resources on JARDIANCE® (empagliflozin) here.

  10. Jardiance (empagliflozin) is used to treat type 2 diabetes, chronic kidney disease and reduce the risk of heart failure and cardiovascular disease. Includes Jardiance side effects, interactions, and indications.

  11. Jardiance (empagliflozin) - Uses, Side Effects, and More - WebMD

    www.webmd.com/drugs/2/drug-166762/jardiance-oral

    For more information about Jardiance, you can visit the manufacturer’s website at www.jardiance.com or call them at 800-542-6257.